Linked research, clinical, and regulatory source pathways.
Company profile
About Surgical Science
Surgical Science is a leading provider of medical simulation training and software solutions headquartered in Gothenburg, Sweden. The company develops evidence-based, high-fidelity virtual reality simulators that enable healthcare professionals to safely advance their skills—from essential techniques to managing complex cases—without putting patients at risk. With over 11,000 simulators deployed in more than 90 countries, Surgical Science supports training across 150+ medical procedures spanning laparoscopic surgery, robotic surgery, endoscopy, ultrasound, endovascular interventions, and arthroscopy. The company's product portfolio includes comprehensive platforms like LAP Mentor, LapSim, ANGIO Mentor, and RobotiX Mentor, as well as specialized simulators for ultrasound (ScanTrainer, HeartWorks), bronchoscopy (BRONCH Mentor), and gastrointestinal endoscopy (GI Mentor). Surgical Science partners with all leading robotic surgery companies, powering their hardware with proprietary simulation software. Beyond healthcare education, the company provides customized simulation solutions for medical device manufacturers to support product development, sales demonstrations, clinical trials, and user adoption. With over 400 validation studies supporting its technology, Surgical Science is committed to enhancing patient safety and healthcare outcomes through proficiency-based simulation training that has been shown to significantly reduce surgical errors and shorten learning curves.
Company description Surgical Science official website
Primary marketMedical Education & Training
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Surgical Science?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Arthroscopy
- Bronchoscopy
- Echocardiography
- Endovascular interventions
- Gastrointestinal endoscopy
- Hysteroscopy
- Laparoscopic surgery
- Pediatric and neonatal ultrasound
- Point-of-Care ultrasound
- Robotic surgery
- Trans-Esophageal Echocardiography
- Ultrasound imaging
- Urology procedures
Who it serves
- Healthcare professionals and surgical teams
- Hospitals and health systems
- Medical device manufacturers
- Medical education institutions
- Pharmaceutical companies
- Robotic surgery companies
Deployment & integration
Deployment information is currently being developed.
Recorded integration context: Custom hardware integrations for MedTech partners, Original medical device instruments, Robotic surgery consoles from all leading manufacturers.
Geographic context
Markets90+ countries globally · France · Germany · Ireland · Israel · Scotland · Sweden · UK · USA
Company sourceOfficial website
Company milestones
Platform expansion
Major upgrade to Endometriosis Ultrasound Simulator (March 2025), joined SEISMIC consortium (February 2025), appointed Linus Bergqvist as Chief Operating Officer (January 2025)
Partnerships
Recorded partners
- Academic institutions including Karolinska Hospital
- All leading robotic surgery companies
- CHEST (The American College of Chest Physicians)
- SEISMIC consortium
- Sheba Medical Center
- UC Davis
- University of Rochester Medical Center
- University of Twente
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
No source-backed Company products are currently listed.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
The role of gut microbiota in chronic intestinal pseudo-obstruction: exploring fecal microbiota transplantation as a treatment option.Gut microbes · Dec 31, 2026
Noninvasive imaging for the evaluation of JAK inhibitors efficacy in the management of facial vitiligo.The Journal of dermatological treatment · Dec 1, 2026
Management of adult vitiligo: approved topical JAK inhibitor and standard therapies.The Journal of dermatological treatment · Dec 1, 2026
Comparison of intra-articular injectable polydactyly-derived chondrocyte sheet-minis with direct transplantation of intact polydactyly-derived chondrocyte sheets in a rat full-thickness cartilage defect model.Regenerative therapy · Dec 1, 2026
Clinical profile, patient experience, and management of vitiligo in Italy: Data from the National 2024 Vitiligo Week Awareness Campaign.JAAD international · Oct 1, 2026
Accidental fish bone ingestion complicated by gastric abscess: A case report.Radiology case reports · Oct 1, 2026
Clinical validation
Clinical-trial records
Multicenter Single-Blind RCT of CTIF Versus LNF For Treatment of GERD in Patients Requiring Hiatal Hernia RepairNCT04795934 · Sponsor · ACTIVE NOT RECRUITING
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
60% reduction in surgical errors
Residents performing first 10 laparoscopic cholecystectomies after proficiency-based simulation training (Karolinska Hospital study)
Shortened learning curve
Trainees gain confidence and proficiency before approaching first real cases
Reduced adverse events
Evidence-based training improves patient outcomes and quality of life
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Surgical Science
Recent articles published on Surgical Science's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Medical Education & Training
Companies using AI, virtual reality, augmented reality, or immersive technologies to provide medical education, surgical training, clinical skills development, or continuing medical education for healthcare professionals. Focuses on training and skills development rather than direct patient care delivery.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.